Family Firm Inc. Takes $156,000 Position in Danaher Co. (NYSE:DHR)

Family Firm Inc. purchased a new position in Danaher Co. (NYSE:DHR) during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 624 shares of the conglomerate’s stock, valued at approximately $156,000.

Several other institutional investors also recently bought and sold shares of the company. Tsfg LLC grew its holdings in shares of Danaher by 733.3% during the first quarter. Tsfg LLC now owns 100 shares of the conglomerate’s stock valued at $25,000 after buying an additional 88 shares during the last quarter. CarsonAllaria Wealth Management Ltd. bought a new position in shares of Danaher in the 2nd quarter worth approximately $25,000. Cape Investment Advisory Inc. purchased a new position in shares of Danaher in the fourth quarter worth approximately $25,000. Redmont Wealth Advisors LLC bought a new stake in Danaher during the first quarter valued at approximately $30,000. Finally, Richardson Financial Services Inc. purchased a new stake in Danaher during the fourth quarter valued at approximately $42,000. 79.05% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of brokerages have recently issued reports on DHR. Robert W. Baird boosted their price objective on shares of Danaher from $271.00 to $278.00 and gave the company an “outperform” rating in a research report on Wednesday, July 24th. TD Cowen upped their price target on Danaher from $290.00 to $310.00 and gave the stock a “buy” rating in a research report on Wednesday, July 24th. StockNews.com cut Danaher from a “buy” rating to a “hold” rating in a research report on Tuesday, June 25th. Barclays upped their price target on Danaher from $270.00 to $285.00 and gave the stock an “equal weight” rating in a research report on Wednesday, July 24th. Finally, Royal Bank of Canada upped their price target on Danaher from $297.00 to $300.00 and gave the stock an “outperform” rating in a research report on Wednesday, July 24th. Six research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $276.88.

Insider Activity at Danaher

In related news, SVP Brian W. Ellis sold 9,600 shares of the stock in a transaction that occurred on Thursday, July 25th. The stock was sold at an average price of $275.16, for a total transaction of $2,641,536.00. Following the completion of the transaction, the senior vice president now directly owns 20,230 shares of the company’s stock, valued at $5,566,486.80. The sale was disclosed in a filing with the SEC, which is available through this link. In other news, CEO Rainer Blair sold 9,007 shares of the firm’s stock in a transaction that occurred on Wednesday, July 31st. The stock was sold at an average price of $280.00, for a total value of $2,521,960.00. Following the completion of the sale, the chief executive officer now directly owns 97,983 shares of the company’s stock, valued at approximately $27,435,240. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, SVP Brian W. Ellis sold 9,600 shares of the firm’s stock in a transaction that occurred on Thursday, July 25th. The shares were sold at an average price of $275.16, for a total value of $2,641,536.00. Following the completion of the sale, the senior vice president now directly owns 20,230 shares of the company’s stock, valued at $5,566,486.80. The disclosure for this sale can be found here. Over the last three months, insiders sold 38,707 shares of company stock valued at $10,786,944. Insiders own 11.10% of the company’s stock.

Danaher Price Performance

Shares of NYSE:DHR traded up $1.65 during trading on Friday, hitting $269.48. 1,464,013 shares of the company’s stock were exchanged, compared to its average volume of 2,820,898. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.43 and a quick ratio of 1.04. Danaher Co. has a 52-week low of $182.09 and a 52-week high of $281.70. The business’s 50-day simple moving average is $258.72 and its 200 day simple moving average is $254.34. The company has a market cap of $199.60 billion, a price-to-earnings ratio of 45.67, a PEG ratio of 4.62 and a beta of 0.83.

Danaher (NYSE:DHR) last released its earnings results on Tuesday, July 23rd. The conglomerate reported $1.72 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.57 by $0.15. Danaher had a return on equity of 11.06% and a net margin of 16.94%. The firm had revenue of $5.74 billion during the quarter, compared to analysts’ expectations of $5.59 billion. During the same quarter last year, the business posted $2.05 earnings per share. The firm’s revenue was down 2.9% on a year-over-year basis. As a group, equities analysts predict that Danaher Co. will post 7.59 EPS for the current year.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.